Dataset for: Baseline Neutrophil-to-Lymphocyte Ratio is Associated With Poorer Response to Low-Intensity Shockwave Therapy for Erectile Dysfunction: A Two-Centre Retrospective Cohort

This dataset contains the de-identified patient-level data supporting the study "Baseline Neutrophil-to-Lymphocyte Ratio is Associated With Poorer Response to Low-Intensity Shockwave Therapy for Erectile Dysfunction: A Two-Centre Retrospective Cohort," published in Andrologia (2025). The data comprise 260 men from a two-centre retrospective cohort: 160 patients with erectile dysfunction (ED) treated with a standardized 12-session low-intensity extracorporeal shockwave therapy (Li-ESWT) protocol, and 100 control men without ED (IIEF-5 ≥ 22) included for baseline comparisons only. One row corresponds to one participant. Variable dictionary (columns):- id: participant identifier (1–260)- code: masked participant code (first two letters of given name, remainder masked)- age: age in years- bmi: body mass index (kg/m²)- hypertension: 0 = no, 1 = yes- diabetes: 0 = no, 1 = yes- hyperlipidemia: 0 = no, 1 = yes- smoking: 0 = no, 1 = yes- group: 0 = non-responder, 1 = responder, 2 = control- nlr: baseline neutrophil-to-lymphocyte ratio- plr: baseline platelet-to-lymphocyte ratio- severity: baseline ED severity (0 = control, 1 = mild, 2 = moderate, 3 = severe)- ed_duration_months: duration of ED in months (controls: not applicable) Notes: Response was defined a priori as ΔIIEF-5 ≥ 4 at Month 6. Controls were included only for baseline descriptive comparisons and were excluded from outcome, ROC, and multivariable analyses. For full methodology, scoring definitions, and statistical analysis, please refer to the associated article (see Related works). The ethics committee approval document is available separately (see Related works).本数据集包含支持发表于《男科》（Andrologia）2025年的研究"基线中性粒细胞与淋巴细胞比值与勃起功能障碍（Erectile Dysfunction，ED）低强度体外冲击波治疗（low-intensity extracorporeal shockwave therapy，Li-ESWT）应答较差相关：一项双中心回顾性队列研究"的去标识化患者层面数据。 本数据集纳入来自双中心回顾性队列的260名男性：其中160名为勃起功能障碍（ED）患者，接受标准化12疗程Li-ESWT方案；另外100名为无ED的对照男性（国际勃起功能指数5（International Index of Erectile Function-5，IIEF-5）≥22），仅用于基线对照。每一行对应一名参与者。 变量字典（列字段）如下： - id：参与者识别码（取值范围1–260） - code：脱敏参与者代码（取名字前两个字母，其余字符脱敏） - age：年龄（单位：岁） - bmi：体重指数（kg/m²） - hypertension：高血压史（0=否，1=是） - diabetes：糖尿病史（0=否，1=是） - hyperlipidemia：高脂血症史（0=否，1=是） - smoking：吸烟史（0=否，1=是） - group：分组（0=无应答者，1=应答者，2=对照组） - nlr：基线中性粒细胞与淋巴细胞比值 - plr：基线血小板与淋巴细胞比值 - severity：基线ED严重程度（0=对照组，1=轻度，2=中度，3=重度） - ed_duration_months：ED病程（单位：月，对照组无对应值） 备注：应答预先定义为第6个月时IIEF-5变化量≥4。对照组仅用于基线描述性对照，未纳入结局、受试者工作特征曲线（Receiver Operating Characteristic，ROC）及多变量分析。完整研究方法、评分定义及统计学分析请参见相关论文（详见关联作品）。伦理委员会批准文件可单独获取（详见关联作品）。